Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges Mer

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
ACS Chemical Biology|January 16, 2015
Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1Michael T Perfetti, Brandi M Baughman, Bradley M Dickson, et al.
The Journal of Biological Chemistry|April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibitionIsaac P Horn, David L Marks, Amanda N Koenig, et al.
Science (New York, N.Y.)|October 7, 2016
Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translationArun Kanakkanthara, Karthik B Jeganathan, Jazeel F Limzerwala, et al.
Nature Chemical Biology|January 13, 2026
GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progressionBingsong Huang, Mingpeng Jin, Gaofeng Cui, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
Nature Genetics|May 3, 2011
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossChristopher J Klein, Maria-Victoria Botuyan, Yanhong Wu, et al.
Brain : a Journal of Neurology|February 14, 2015
Defects of mutant DNMT1 are linked to a spectrum of neurological disordersJonathan Baets, Xiaohui Duan, Yanhong Wu, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
ACS Chemical Biology|January 16, 2015
Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1Michael T Perfetti, Brandi M Baughman, Bradley M Dickson, et al.
The Journal of Biological Chemistry|April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibitionIsaac P Horn, David L Marks, Amanda N Koenig, et al.
Science (New York, N.Y.)|October 7, 2016
Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translationArun Kanakkanthara, Karthik B Jeganathan, Jazeel F Limzerwala, et al.
Nature Chemical Biology|January 13, 2026
GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progressionBingsong Huang, Mingpeng Jin, Gaofeng Cui, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
Nature Genetics|May 3, 2011
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossChristopher J Klein, Maria-Victoria Botuyan, Yanhong Wu, et al.
Brain : a Journal of Neurology|February 14, 2015
Defects of mutant DNMT1 are linked to a spectrum of neurological disordersJonathan Baets, Xiaohui Duan, Yanhong Wu, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Pageof 7